Stocks
Axsome Therapeutics (AXSM) Net margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -395.2% | -88.4% | -91.9% | |||||
| Changes by years, y/y, % | +307pp | -77.6% | |||||||
Axsome Therapeutics. Net margin, %
Axsome Therapeutics. Net margin, changes, pp
Axsome Therapeutics (AXSM) Net margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Net margin, % | ? | -107.6% | -137.9% | -91.1% | -91.0% | -61.7% | -91.9% | |
| Changes by years, y/y, % | +173pp | +136pp | -79pp | +53pp | +46pp | |||
| Changes by quarters, q/q, % | +36pp | -30pp | +47pp | +0pp | +29pp | |||
